AstraZeneca Rejects Pfizer “Final” Offer; Doubts Rise Over Eventual Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca received and rejected Pfizer’s latest, higher bid over the weekend, casting real doubt over the US group’s plan for a merger to create the world's biggest drugmaker – but analysts say Pfizer, which says it won’t turn hostile, could raise its offer one last time.